New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive treatments—such as monoclonal antibodies—sooner.

Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't ...

The test, a decade in the making, is being touted by UCSD physicians as addressing "a critical diagnostic gap, providing ...

Feeling tired, moody, or weak can be early signs that your body needs a blood check. Doctors say regular blood tests help ...

A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...

While starting fat loss or fitness journey, it is imperative to understand that apart from diet and exercise being the center ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether a patient's memory problems are likely caused by Alzheimer's disease. The new test, called ...

FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

(CNN) — The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of ...

The Food and Drug Administration has given approval for a blood test that will rule out if someone has Alzheimer’s disease and other cognitive issues when they have the symptoms of the conditions. It ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...